Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Establishment of the EurocanPlatform

Dr Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden

Establishment of the EurocanPlatform ( Dr Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden )

Evolution of the EurocanPlatform

Prof Julio Celis – Danish Cancer Society, Institute of Cancer Biology, Copenhagen, Denmark

Evolution of the EurocanPlatform ( Prof Julio Celis – Danish Cancer Society, Institute of Cancer Biology, Copenhagen, Denmark )

European Thoracic Oncology Platform

Dr Solange Peters - Lausanne University, Switzerland

European Thoracic Oncology Platform ( Dr Solange Peters - Lausanne University, Switzerland )

How do we design trials that improve outcome?

Dr Lisa Carey - University of North Carolina, Chapel Hill, USA

How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )

Goal of the 2013 WIN Symposium

Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller

Goal of the 2013 WIN Symposium ( Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller )

Racial disparities in cancer outcomes

Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA

Racial disparities in cancer outcomes ( Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA )

Japan Myeloma Network

Dr Hiroshi Kosugi - Ogaki Municipal Hospital, Ogaki, Japan

Japan Myeloma Network ( Dr Hiroshi Kosugi - Ogaki Municipal Hospital, Ogaki, Japan )

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (4/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (4/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (3/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (3/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (2/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (2/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (1/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (1/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )

More from ecancer